Literature DB >> 16177930

[The role of epidemiological quality parameters in a mammography screening programme].

N Becker1.   

Abstract

In the recently established mammography screening programme, for the first time in Germany an extensive data collection for prompt quantification of specified quality parameters will be intrinsic to an early detection programme. Epidemiological parameters taken from the European Guidelines are central. This article outlines how epidemiology is involved in quality assurance of cancer screening and why epidemiological quality indicators will be quantified. The reasons for focussing on those parameters, on which the European Guidelines and now the German programme are based, and their significance in the long-term effectiveness of this programme are explained.

Entities:  

Mesh:

Year:  2006        PMID: 16177930     DOI: 10.1007/s00117-005-1273-3

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  13 in total

1.  [Screening from the epidemiological viewpoint].

Authors:  N Becker
Journal:  Radiologe       Date:  2002-08       Impact factor: 0.635

2.  [Introduction of a mammography screening program in Germany. Consideration of benefits and risks].

Authors:  E A Nekolla; J Griebel; G Brix
Journal:  Radiologe       Date:  2005-03       Impact factor: 0.635

3.  Some random-effects models for the analysis of matched-cluster randomised trials: application to the Swedish two-county trial of breast-cancer screening.

Authors:  R Nixon; T C Prevost; S W Duffy; L Tabar; B Vitak; H H Chen
Journal:  J Epidemiol Biostat       Date:  2000

Review 4.  Long-term effects of mammography screening: updated overview of the Swedish randomised trials.

Authors:  Lennarth Nyström; Ingvar Andersson; Nils Bjurstam; Jan Frisell; Bo Nordenskjöld; Lars Erik Rutqvist
Journal:  Lancet       Date:  2002-03-16       Impact factor: 79.321

5.  Cochrane review on screening for breast cancer with mammography.

Authors:  O Olsen; P C Gøtzsche
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

6.  The natural history of breast carcinoma: what have we learned from screening?

Authors:  L Tabár; S W Duffy; B Vitak; H H Chen; T C Prevost
Journal:  Cancer       Date:  1999-08-01       Impact factor: 6.860

7.  Is screening for breast cancer with mammography justifiable?

Authors:  P C Gøtzsche; O Olsen
Journal:  Lancet       Date:  2000-01-08       Impact factor: 79.321

8.  Predicting the cumulative risk of false-positive mammograms.

Authors:  C L Christiansen; F Wang; M B Barton; W Kreuter; J G Elmore; A E Gelfand; S W Fletcher
Journal:  J Natl Cancer Inst       Date:  2000-10-18       Impact factor: 13.506

9.  [Population-based cancer registration in Germany. Essentials and perspectives].

Authors:  A Katalinic
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2004-05       Impact factor: 1.513

10.  Breast cancer screening programmes: the development of a monitoring and evaluation system.

Authors:  N E Day; D R Williams; K T Khaw
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

View more
  2 in total

Review 1.  [Mammography screening].

Authors:  R Schulz-Wendtland; N Becker; K Bock; K Anders; W Bautz
Journal:  Radiologe       Date:  2007-04       Impact factor: 0.635

2.  Benefit and risk of mammography screening: considerations from an epidemiological viewpoint.

Authors:  Nikolaus Becker; Hans Junkermann
Journal:  Dtsch Arztebl Int       Date:  2008-02-22       Impact factor: 5.594

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.